QUOTED. 13 September 2019. Andrew Holden.
Executive Summary
The first large randomized trial of drug-coated balloons to treat hemodialysis arteriovenous access stenoses showed Medtronic's IN.Pact AV paclitaxel-coated angioplasty balloon produces superior outcomes compared to standard angioplasty balloons. See what one of the trial’s primary investigators, Andrew Holden, said about it here.
“It is always challenging to perform the first major randomized controlled trial, and there were lessons learnt from the Lutonix AV Access IDE trial that helped in planning the Medtronic IN.PACT AV Access study.” – Andrew Holden, New Zealand's Auckland University
- Find out more: Medtronic’s In.Pact AV Drug-Coated Balloon Effectively Treats Hemodialysis Access Lesions In Trial
Click here for a free trial of Medtech Insight